The Center for Rare and Neglected Diseases has built partnerships between Notre Dame researchers and pharmaceutical companies to translate drug and genetics research into new therapies that reach the clinic. We develop treatments for multiple rare and neglected diseases. Currently a new formulation of an FDA approved drug is moving forward for testing in patients with Niemann Pick Type C as well as other neurological diseases and cancers. CRND faculty also work with patients and their families, healthcare providers, federal organizations, Notre Dame students and fellows, to broadly support research to better understand rare neurological diseases, rare cancers and rare resistant infection and develop precision medicine therapies for these diseases.
During this exciting time, we have the unique opportunity to earn a portion of a $1 Million! Make a $10 gift on Notre Dame Day (April 23 – 24), and receive 5 votes to cast. The total number of votes we receive decides our percentage of the $1 Million. Please vote for us!
We encounter many requests for assistance from rare disease families. Your financial contribution will help us to give them a chance. If you believe in research and education that can transform a child's life, now would be a perfect time to give. Our successes cannot be possible without your partnership, commitment and support. We thank you. Every step, even small ones, enables us to envision future possibilities.